GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Definitive Healthcare Corp (NAS:DH) » Definitions » Capex-to-Operating-Cash-Flow

DH (Definitive Healthcare) Capex-to-Operating-Cash-Flow : 0.30 (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Definitive Healthcare Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

Definitive Healthcare's Capital Expenditure for the three months ended in Mar. 2025 was $-7.71 Mil. Its Cash Flow from Operations for the three months ended in Mar. 2025 was $26.07 Mil.

Hence, Definitive Healthcare's Capex-to-Operating-Cash-Flow for the three months ended in Mar. 2025 was 0.30.


Definitive Healthcare Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for Definitive Healthcare's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Definitive Healthcare Capex-to-Operating-Cash-Flow Chart

Definitive Healthcare Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capex-to-Operating-Cash-Flow
Get a 7-Day Free Trial 0.06 0.27 0.23 0.07 0.21

Definitive Healthcare Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.03 0.04 1.34 0.30

Competitive Comparison of Definitive Healthcare's Capex-to-Operating-Cash-Flow

For the Health Information Services subindustry, Definitive Healthcare's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Definitive Healthcare's Capex-to-Operating-Cash-Flow Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Definitive Healthcare's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Definitive Healthcare's Capex-to-Operating-Cash-Flow falls into.


;
;

Definitive Healthcare Capex-to-Operating-Cash-Flow Calculation

Definitive Healthcare's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Dec. 2024 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-12.344) / 58.196
=0.21

Definitive Healthcare's Capex-to-Operating-Cash-Flow for the quarter that ended in Mar. 2025 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-7.706) / 26.066
=0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Definitive Healthcare  (NAS:DH) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


Definitive Healthcare Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Definitive Healthcare's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Definitive Healthcare Business Description

Traded in Other Exchanges
N/A
Address
492 Old Connecticut Path, Suite 401, Framingham, MA, USA, 01701
Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.
Executives
Carrie Lazorchak officer: Chief Revenue Officer C/O DEFINITIVE HEALTHCARE CORP., 492 OLD CONNECTICUT PATH, SUITE 401, FRAMINGHAM MA 01701
Scott G Stephenson director C/O VERISK ANALYTICS, INC., 545 WASHINGTON BOULEVARD, JERSEY CITY NJ 07310-1686
Sea Vii Management, Llc director, 10 percent owner ONE INTERNATIONAL PLACE, SUITE 3520, BOSTON MA 02110
Advent International Gp, Llc director, 10 percent owner 800 BOYLSTON STREET SUITE 3300, BOSTON MA 02199
Spectrum Vii Investment Managers' Fund, L.p. director, 10 percent owner ONE INTERNATIONAL PLACE, 35TH FLOOR, BOSTON MA 02110
Jason Ronald Krantz director, 10 percent owner, officer: Chief Executive Officer C/O DEFINITIVE HEALTHCARE, LLC, 550 COCHITUATE ROAD, FRAMINGHAM MA 01701
Jonathan Maack officer: President C/O DEFINITIVE HEALTHCARE CORP., 550 COCHITUATE RD, FRAMINGHAM MA 01701
Sastry Chilukuri director 5 BUDDY LANE, MORRISTOWN NJ 07960
David Randall Winn director 7900 GLADES ROAD, SUITE 540, BOCA RATON FL 33434
Jeffrey Charles Haywood director, 10 percent owner C/O DEFINITIVE HEALTHCARE, LLC, 550 COCHITUATE ROAD, FRAMINGHAM MA 01701
Richard Douglas Booth officer: Chief Financial Officer 200 CLARENDON STREET, T-9, BOSTON MA 02116
Kathleen A Winters director 101 COLUMBIA ROAD, MORRISTOWN NJ 07960
Spectrum Vii Co-investment Fund, L.p. director, 10 percent owner ONE INTERNATIONAL PLACE, SUITE 3520, BOSTON MA 02110
Advent Global Technology-c Limited Partnership director, 10 percent owner PRUDENTIAL TOWER, 800 BOYLSTON STREET, BOSTON MA 02199-8069
Advent Global Technology-d Limited Partnership director, 10 percent owner PRUDENTIAL TOWER, 800 BOYLSTON STREET, BOSTON MA 02199-8069